Minerva Neurosciences, Inc.NERVNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank57
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Percentile
P57
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-1.10-46.0%
2024-0.76-1922.7%
20230.04-96.3%
20221.12+90.8%
20210.59-98.2%
202033.20+1062.2%
2019-3.45+18.3%
2018-4.22+18.0%
2017-5.15+47.8%
2016-9.87-